In Brief: Generic industry and FDA
Executive Summary
Generic industry and FDA: The National Association of Pharmaceutical Manufacturers, the Generic Pharmaceutical Industry Association and the National Pharmaceutical Association will hold a workshop with FDA Oct. 9-10 at the Hyatt in Bethesda, Md. on technical and regulatory issues facing the generic industry. The workshop will be conducted as three half-day sessions covering the ICH regulatory guidelines, the SUPAC guidelines and the electronic submission of bioavailability data. To register for the workshop contact NAPM...